Atlas Trials

A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps

Clinical trial NCT02623478 · WITHDRAWN

Trial details

NCT number
NCT02623478
Sponsor
Eli Lilly and Company
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 1
Start date
2018-01-01
Primary completion
2018-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.